SCHEMBL22130693

SCHEMBL22130693

O=C1C=Cc2c(c(-c3ccccc3)cn2S(=O)(=O)c2ccc(CO)cc2)C1=O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELAVL1 Q15717 7/20 0.81
HTR6 P50406 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
PARL Q9H300 1/20 0.36
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
ALDH1A1 P00352 2/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
ADAMTS4 O75173 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19737490 0.90 ELAVL1 (1.00) ELAVL1HTR6L3MBTL1CA12CA1
SCHEMBL22130694 0.89 ELAVL1 (0.79) ELAVL1HTR6L3MBTL1CA12CA1
SCHEMBL22130697 0.87 ELAVL1 (0.79) ELAVL1HTR6L3MBTL1CA12CA1
SCHEMBL21222486 0.86 ELAVL1 (1.00) ELAVL1HTR6L3MBTL1CA12CA1
SCHEMBL19737425 0.86 ELAVL1 (0.83) ELAVL1HTR6L3MBTL1CA12CA1
SCHEMBL22130634 0.86 ELAVL1 (0.83) ELAVL1HTR6L3MBTL1CA12CA1
SCHEMBL22130696 0.86 ELAVL1 (0.74) ELAVL1HTR6L3MBTL1CA12CA1
Dimethylamine SCHEMBL21222569 0.85 ELAVL1 (0.90) ELAVL1HTR6L3MBTL1CA12CA1
SCHEMBL22130695 0.85 ELAVL1 (0.76) ELAVL1HTR6L3MBTL1CA12CA9
SCHEMBL22130632 0.83 ELAVL1 (0.77) ELAVL1HTR6L3MBTL1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10689342-B2 Aza-tanshinone derivatives, process for their preparation and their use in therapy UNIVERSITA' DEGLI STUDI DI TRENTO (IT) 2020-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10689342-B2 Aza-tanshinone derivatives, process for their preparation and their use in therapy AZI2, TPMT, TYMS ELAVL1 2765/4885HTR6 1922/4885L3MBTL1 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.